1. All Products
  2. DORA - Oral drugs
  3. ETHIONAMIDE, 250mg, tab., blister
Public Pricelist

ETHIONAMIDE, 250mg, tab., blister

https://medicalguidelines.msf.org/en/node/1216
https://unicat.msf.org/cat/product/12034
STD DORAETHN2T1

Valid Article

Former Code(s): DORAETHN2T-
6.2.5 - Antituberculosis medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J04AD03
Anatomical Therapeutic Chemical Classification according to WHOCC
PM
The order of this product needs to be justified and is only acceptable under certain conditions.
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

ETHIONAMIDE

Therapeutic Action

Thionamide, bacteriostatic

Ethionamide and prothionamide belong to the same therapeutic group.

Indications

Drug-Resistant tuberculosis (DR-TB), in combination with other TB medicines

Some restricted information has been hidden. Sign in to see this information

Instructions for use

The 125 mg dispersible tablet is intended for paediatric use. To be dispersed in 10 ml water.

Must be taken with food and/or at bedtime to limit gastrointestinal disturbances.

Blister packaging is the packaging of choice for antituberculosis medicines due to the unstable nature of some of them when exposed to higher temperatures and humidity.

Bulk packaging (hospital packs) should only be used in special circumstances or in case of unexpected problems in availability of the blister presentation.

The quantity to be ordered is calculated per tablet, not per blister.

Precautions for Use

Do not administer to patients with severe hepatic impairment..

May cause gastrointestinal disturbances.

Contraindicated during pregnancy.

Storage

Below 25°C - Protect from sunlight